Hypomagnesemia
hypomagnesemia diagnosis management
hypomagnesemia causes clinical features ECG magnesium deficiency

This comparative diagnostic image displays two 12-lead electrocardiogram (ECG) strips, labeled A and B, illustrating the cardiac manifestations of hypomagnesemia and its subsequent resolution. Panel A shows a baseline ECG characterized by a prolonged QT interval and significant T-wave inversions, most prominent in the lateral precordial leads (V5, V6) and lead II. These findings are classic markers of electrolyte-induced repolarization abnormalities. Panel B demonstrates the ECG following magnesium supplementation, showing a restoration of normal repolarization. Key changes include the shortening of the QT interval back toward a physiological range and the conversion of previously inverted T-waves to an upright, normal morphology in the lateral leads. The comparison highlights the critical role of magnesium in myocardial electrical stability and is a valuable educational tool for identifying reversible causes of QT prolongation and ST-T segment changes in clinical practice.

This Comparison Chart displays a panel of axial and coronal brain MRI scans from two distinct clinical episodes (First Episode A-E; Second Episode F-J) in a patient with Hypomagnesemia-induced Cerebellar Syndrome (HiCS). The first episode images demonstrate prominent, left-dominant hyperintense signals in the cerebellar hemispheres on T2-weighted (A), FLAIR (B), and DWI (C) sequences. The ADC map (D) also shows hyperintensity, suggesting vasogenic edema rather than cytotoxic edema. Corresponding T1-weighted images with gadolinium (E) show hypointense lesions without contrast enhancement. In the second episode, follow-up imaging (F-J) reveals a significant reduction in the size and signal intensity of the cerebellar abnormalities. While residual hyperintensity persists on T2W (F), FLAIR (G), and ADC (I), the DWI sequence (H) has normalized. These findings illustrate the characteristic reversible or partially reversible cerebellar edema associated with profound magnesium deficiency, which can mimic subacute stroke or cerebellitis but typically lacks contrast enhancement and restricted diffusion.

This composite educational graphic consists of two panels focusing on the clinical management of electrolyte imbalances and their cardiac manifestations. Panel A is a dual-axis timeline graph illustrating the longitudinal relationship between serum magnesium levels and the corrected QT interval (QTc). The x-axis tracks time in days (up to day 53). The left y-axis measures serum magnesium (mg/dL, black solid line), showing fluctuations often below the reference range (1.5-2.7 mg/dL). The right y-axis measures the QTc interval (msec/100, red dashed line). Red arrows indicate points of intravenous magnesium supplementation, and a green triangle marks the initiation of vitamin D supplementation, which correlates with the eventual stabilization of magnesium levels and normalization of the QTc interval. Panel B displays a standard 12-lead electrocardiogram (ECG) captured one month after discharge. It shows a normal sinus rhythm with regular P waves, QRS complexes, and T waves. The precordial leads (V1-V6) demonstrate appropriate R-wave progression. This figure illustrates the pathophysiology of secondary long QT syndrome due to refractory hypomagnesemia and the clinical impact of corrective biochemical interventions on cardiac repolarization.

This pathophysiology diagram illustrates the role of magnesium in migraine pathogenesis and synaptic transmission. The top section compares a synapse under 'NORMAL Mg2+' conditions with one in 'HYPOMAGNESEMIA'. In the normal state, the NMDA receptor is shown with a magnesium block, regulating calcium (Ca++) entry. In the hypomagnesemia state, the block is absent, leading to 'NMDA-r Dysfunction' and increased ion flux. The diagram depicts key synaptic components including the presynaptic membrane with neurotransmitter vesicles, the postsynaptic membrane with AMPA and NMDA receptors, and glutamic acid signaling. The central flow shows how hypomagnesemia contributes to Cortical Spreading Depression (CSD), indicated on a brain illustration. Additional contributory factors shown include CGRP release, oxidative stress, neuroinflammation, and other trigger factors. The culmination of these processes is linked to 'migraine aura/attack,' represented by a facial illustration and a brain with focal excitatory waves. This diagram is designed for neurology and biochemistry education to explain the molecular mechanisms of magnesium deficiency in migraine development.
FEMg = (U_Mg × P_Cr) / (P_Mg × 0.7 × U_Cr) × 100
| Drug/Cause | Mechanism |
|---|---|
| Loop diuretics (furosemide) | Block NKCC2 in TAL, reduce paracellular Mg reabsorption |
| Thiazide diuretics | Block NCC in DCT |
| Aminoglycosides | Direct tubular toxicity |
| Cisplatin | Tubular damage, persistent renal Mg wasting |
| Amphotericin B | Renal tubular toxicity |
| Cyclosporine / Tacrolimus | Calcineurin inhibitors - impair TRPM6 |
| Proton pump inhibitors | Impair intestinal and renal Mg handling |
| Pentamidine | Tubular damage |
| Hypercalcemia | Ca²⁺ competes with Mg²⁺ in TAL |
| Osmotic diuresis (DKA, glycosuria) | Volume expansion reduces tubular reabsorption |
| Volume expansion | Increased tubular flow reduces Mg reabsorption |
| Category | Examples |
|---|---|
| Hypercalciuric hypomagnesemias (TAL defects) | Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) - mutations in CLDN16 or CLDN19 |
| Gitelman-like (DCT defects) | Gitelman syndrome (SLC12A3), Bartter syndrome (types 3 & 4), EAST syndrome (KCNJ10), HNF1B nephropathy |
| Mitochondrial | Mitochondrial metabolic syndromes, Kearns-Sayre syndrome |
| Other | Hypomagnesemia with secondary hypocalcemia (TRPM6 mutations), hypomagnesemia with seizures & mental retardation (CNNM2), hypomagnesemia with abnormal EGF signaling |


| Renal Wasting | GI/Dietary | |
|---|---|---|
| FEMg | > 2-4% | < 2% |
| 24h urine Mg | > 24 mg | Low |
| Feature | Detail |
|---|---|
| Most common drug cause | Loop diuretics |
| Classic arrhythmia | Torsades de pointes |
| Refractory hypokalemia | Think hypomagnesemia |
| Refractory hypocalcemia | Think hypomagnesemia (check Mg before treating Ca) |
| Alcoholism | Triple threat: poor intake + GI loss + renal loss |
| PPI long-term use | PPI-induced hypomagnesemia (often underdiagnosed) |
| Post-cardiac surgery ICU | High risk; treat empirically if < 1.2 mg/dL |
| Digoxin use | Hypomagnesemia dramatically increases digoxin toxicity |